J. Stark Thompson, Tom Daniel, Mark Carthy, Ronald Lindsay | GenomeWeb

Luminex this week announced that the appointment of J. Stark Thompson to the board of directors, where he will serve as a class III director. Most recently, Thompson served as president, CEO and Director of Life Technologies. Thompson has a BS from Muskingum College and a MS and PhD in Physiological Chemistry from Ohio State University. He currently serves as chair of the board of directors of Gene Logic, as well as serving as a director in various other private and civic organizations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.